Physician profile
Jennifer Kiel
NPI 1841786753
$5,914.41
in general payments reported to CMS, 2019-2025
18 companies · $1,305 in 2025
The $1,305 reported for 2025 was more than what 75% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $127 · 2021: $117 · 2022: $340 · 2023: $3,399 · 2024: $482 · 2025: $1,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,139 · Food and Beverage: $1,127 · Travel and Lodging: $919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,138.93 |
| Food and Beverage | $1,127.24 |
| Travel and Lodging | $919.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,454.21 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $1,054.73 | 2025 | Phasix Mesh |
| Bard Peripheral Vascular, INC. | $180.16 | 2022 | |
| Integra Lifesciences Corporation | $176.28 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $158.75 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bard Access Systems, INC. | $127.13 | 2020 | |
| Janssen Pharmaceuticals, INC | $116.93 | 2021 | |
| Kci USA, INC. | $114.87 | 2019-2022 | |
| Cardiva Medical, INC. | $111.79 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs |
| Hologic Sales and Service, LLC | $80.21 | 2025 | Localizer, Magseed |
| Tactile Systems Technology INC | $75.00 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Solventum Corporation | $64.96 | 2024-2025 | Activ.A.C., 3m Coban, Promogran Prisma |
| Globus Medical, INC. | $57.20 | 2025 | Senza |
| Kls-Martin L.P. | $45.19 | 2019 | |
| Medtronic, INC. | $40.69 | 2025 | Transorb |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endogastric Solutions, INC | $22.19 | 2024 | Esophyx |
| Baxter Healthcare | $17.61 | 2024 | Perclot |
| Stryker Corporation | $16.51 | 2025 | Spy-Phi System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Kiel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.